药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Biperiden
Fingolimod
Estramustine may increase the immunosuppressive activities of Fingolimod.
Biperiden
Tofacitinib
Estramustine may increase the immunosuppressive activities of Tofacitinib.
Biperiden
Calcium polycarbophil
Calcium polycarbophil can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Biperiden
Calcium pangamate
Calcium pangamate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Biperiden
Calcium lactate gluconate
Calcium lactate gluconate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Biperiden
Calcium lactate
Calcium lactate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Biperiden
Calcium Phosphate
Calcium Phosphate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Biperiden
Calcium gluconate
Calcium gluconate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Biperiden
Calcium citrate
Calcium citrate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Biperiden
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Biperiden
Calcium
Calcium can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Biperiden
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Estramustine.
Biperiden
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Estramustine.
Biperiden
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Estramustine.
Biperiden
Roflumilast
Roflumilast may increase the immunosuppressive activities of Estramustine.
Biperiden
Difluocortolone
The risk or severity of adverse effects can be increased when Estramustine is combined with Difluocortolone.
Biperiden
Clobetasol
The risk or severity of adverse effects can be increased when Estramustine is combined with Clobetasol.
Biperiden
Fluocortolone
The risk or severity of adverse effects can be increased when Estramustine is combined with Fluocortolone.
Biperiden
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Estramustine is combined with Hydrocortisone butyrate.
Biperiden
Fluocinonide
The risk or severity of adverse effects can be increased when Fluocinonide is combined with Estramustine.